Smithsonian Magazine on MSN
A New Trial Put Immune System-Boosting Therapies to the Test to Fight HIV, Raising Hopes for Keeping the Virus at Bay
In the small study, seven out of ten participants maintained low levels of HIV for several months after receiving the ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...
Scientists tested a multi-step immune-based therapy designed to retrain the body to control HIV without continuous antiviral treatment.
Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV ...
3don MSN
Common water pill may help HIV medicines work faster and reduce inflammation, early study suggests
An FDA‑approved medication called spironolactone, often prescribed for heart and blood pressure conditions, may be a useful ...
UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...
New HIV cases in Michigan have “significantly declined” over the last decade, data from the Michigan Department of Health and ...
UCSF researchers have found a treatment for HIV that shows potential as a long-term solution for the chronic disease that, up ...
For the University of California, San Francisco (UCSF) study, 10 people living with HIV took a mix of experimental ...
Study from the Ragon Institute of Mass General Brigham, MIT and Harvard has found a property of a specific kind of immune cell that may explain why some people can keep HIV in check Insight could be h ...
Pharmaceutical Technology on MSN
“Sharp” funding cuts disrupt PrEP access to millions of HIV patients
While the WHO is still assessing the scale of the impact of foreign aid cuts, access to PrEP medication is believed to have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results